Biography
Anthony Chalmers is Chair of Clinical Oncology at the University of Glasgow. His clinical practice at the Beatson West of Scotland Cancer Centre is devoted to the treatment of patients with brain tumours, and he runs the Translational Radiation Biology laboratory in the Institute for Cancer Sciences. His main research interest is in improving outcomes for patients with glioblastoma by combining radiotherapy with targeted drug therapy, but his research interest in radiotherapy-drug combinations extend across tumour sites. He is Deputy Chair of the NCRI Clinical and Translational Radiotherapy Research Working Group (CTRad) and leads the CTRad Radiotherapy-Drug Combinations Consortium. He is also vice-chair of the CRUK Clinical Trials Awards and Advisory Committee (CTAAC) and is on the Scientific Committees of the European Association for Neuro-Oncology (EANO) and the European Society for Therapeutic Radiation Oncology (ESTRO). Prior to taking up his post in Glasgow in September 2010 he studied at Oxford University Medical School and UCLA and has worked in a number of cancer centres in the UK including the Royal Marsden Hospital, Mount Vernon Hospital, the Middlesex Hospital and the Sussex Cancer Centre in Brighton. His scientific training has taken place at the Gray Cancer Institute, where he undertook a PhD in Radiation Biology, and the MRC Genome Damage and Stability Centre at the University of Sussex. Since arriving in Glasgow he has established the Scottish Radiotherapy Research Forum and is committed to increasing clinical and pre-clinical radiotherapy research activity in Scotland.
Education and qualifications
- 2005: PhD University of London (Gray Cancer Institute)
- 2000: FRCR (UK)
- 1995: MRCP (UK)
- 1992: BM BCh (University of Oxford)
- 1989: BA (Hons) (University of Oxford)
Appointments
- 2010-present: Chair of Clinical Oncology, University of Glasgow and Honorary Consultant, Beatson West of Scotland Cancer Centre
- 2009-present: MRC Senior Clinical Fellow
- 2004-2010: Senior Lecturer and Honorary Consultant in Clinical Oncology, Brighton and Sussex Medical School
- 2004-2008: MRC Clinician Scientist
- 1996-2004: Specialist Registrar in Clinical Oncology (Pan-Thames Rotation)
- 2000-2003: Clinical Research Fellow, Gray Cancer Institute, Mount Vernon Hospital
Committee membership
- 2009-present: FRCR Part 1 examination board
- 2009-present: NCRI Clinical and Translational Radiotherapy Working Group
- 2008-present: British Neuro-Oncology Society, member of council
- 2007-present: NCRI Brain Tumour Clinical Studies Group
- 2007-present: NCRI Brain Tumour Group – Novel Agents Sub-Group
- 2007-present: EORTC Brain Tumour Group
 |
 |
 |
 |